COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES

COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES

.

Bibliographic Details
Main Authors:	R. G. Oganov, I. N. Denisov, V. I. Simanenkov, I. G. Bakulin, N. V. Bakulina, S. A. Boldueva, O. N Barbarash, N. P Garganeeva, V. L Doshchitsin, O. M. Drapkina, E. N. Dudinskaya, Yu. V. Kotovskaya, A. M. Lila, M. N. Mamedov, B. U. Mardanov, O. N. Miller, M. M. Petrova, Yu. M. Pozdnyakov, N. K. Runikhina, S. A. Sayganov, A. V. Tarasov, O. N. Tkacheva, A. M. Urinsky, S. A. Shalnova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2017-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	сердечно-сосудистые заболевания сердечно-сосудистый континуум коморбидная патология метаболический синдром гериатрическая коморбидность первичная и вторичная профилактика рациональная фармакотерапия
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/712

Similar Items

ДИСЛИПИДЕМИИ: ОБЗОР РЕКОМЕНДАЦИЙ ESC/EAS 2019 ПО ДИАГНОСТИКЕ И ЛЕЧЕНИЮ. ЧАСТЬ 2 – ТАРГЕТНАЯ ТЕРАПИЯ
by: V. M. Pyrochkin, et al.
Published: (2021-05-01)

VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT
by: R. G. Oganov
Published: (2015-09-01)

АЛГОРИТМ СТРАТИФИКАЦИИ СЕРДЕЧНО-СОСУДИСТОГО РИСКА У МУЖЧИН В ВОЗРАСТЕ 18-29 ЛЕТ С СИНДРОМОМ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
by: A. N. Zayats, et al.
Published: (2021-05-01)

SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS
by: M. N. Mamedov, et al.
Published: (2015-12-01)

CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE
by: M. I. Shupina, et al.
Published: (2015-09-01)

THE STATE OF ARTERIAL HYPERTENSION DIAGNOSTICS AND TREATMENT, ACCORDING TO THE RESULTS OF THE POLL AMONG PHYSICIANS OF VOLGOGRAD AND VOLGOGRAD REGION
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

ВЛИЯНИЕ ОБРАЗОВАТЕЛЬНОГО СТАТУСА МУЖЧИН И ЖЕНЩИН НА РИСК ФАТАЛЬНЫХ СЕРДЕЧНО-СОСУДИСТЫХ ОСЛОЖНЕНИЙ
by: E. A. Sharlaeva, et al.
Published: (2015-11-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE
by: A. V. Kontsevaya, et al.
Published: (2016-01-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

THE USE OF MULTI-COMPONENT THERAPY IN THE MANAGEMENT OF METABOLIC SYNDROME
by: S. V. Nedogoda, et al.
Published: (2016-02-01)

Klinicheskoe znachenie disfunktsii endoteliya pri arterial'noy gipertonii
by: D V Nebieridze
Published: (2005-03-01)

Rasprostranennost' ozhireniya,kardiometabolicheskikh faktorov riska,metabolicheskogo sindroma i sakharnogo diabetasredi zhenshchin razlichnykh vozrastnykh gruppMoskovskogo regiona
Published: (2009-12-01)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
by: G Mancia, et al.
Published: (2013-09-01)

CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: D. A. Anichkov, et al.
Published: (2016-01-01)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)

Ацетилсалициловая кислота в первичной профилактике сердечно-сосудистых заболеваний: уточненные данные
Published: (2018-06-01)

Some aspects of periodontal disease and comorbid cardiovascular diseases
by: D. I. Trukhan, et al.
Published: (2015-12-01)

Total glucose control: the role of post-prandial glucose
by: PAUL S JELLINGER
Published: (2004-06-01)

Cardioselective β-blockers in the treatment of CHF in the practice of primary care physician
by: AM Shilov, et al.
Published: (2014-12-01)

EPICARDIAL FAT: A STRIKER OR A SPARE?
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Cardiovascular risk factors and diabetic foot syndrome in south indian diabetic population
by: M M Rennis, et al.
Published: (2011-06-01)

MULTI-CHANNEL VOLUME SPHYGMOGRAPHY IN CARDIOANGIOLOGICAL SCREENING OF THE ADULT POPULATION
by: R. A. Khokhlov, et al.
Published: (2015-09-01)

Ratsional'naya farmakoterapiya arterial'noy gipertenzii i assotsiirovannykh sostoyaniy: v fokuse – antagonisty kal'tsiya
by: Vladislav Vasil'evich Kosarev, et al.
Published: (2013-09-01)

Alogliptin – the new member of DPP-4 inhibitors class
by: Nina Aleksandrovna Petunina, et al.
Published: (2014-12-01)

Visceral obesity and cardiometabolic risk: features of hormonal and immune regulation
by: Irina V. Kologrivova, et al.
Published: (2017-11-01)

SNIZhENIE MINERAL'NOY PLOTNOSTI KOSTNOY TKANI -DOPOLNITEL'NYY KRITERIY STRATIFIKATsII SERDEChNOSOSUDISTOGO RISKA U ZhENShchIN POSTMENOPAUZAL'NOGO PERIODA S ARTERIAL'NOY GIPERTONIEY
by: N Yu Khozyainova, et al.
Published: (2010-12-01)

Преимущества оптимизации алгоритма терапии статинами в амбулаторной практике
Published: (2021-03-01)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
by: G Mancia, et al.
Published: (2013-12-01)

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. M. Loukianov, et al.
Published: (2015-09-01)

STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR?
by: R. G. Oganov, et al.
Published: (2015-12-01)

EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS
by: E. V. Akhmedova, et al.
Published: (2015-09-01)

STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01)

SLEEP DURATION: MODERN VIEW OF THE PROBLEM FROM THE STANDPOINT OF A CARDIOLOGIST
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Vybor antigipertenzivnogo preparata s pozitsiy ratsional'noy farmakoterapii
by: Dmitriy Ivanovich Trukhan, et al.
Published: (2013-09-01)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

Diagnosis and treatment of arterial hypertension [Guidelines]
by: I E Chazova, et al.
Published: (2019-03-01)